XML 28 R17.htm IDEA: XBRL DOCUMENT
v3.25.0.1

STOCKHOLDERS' EQUITY | 6 Months Ended
--- | ---
Dec. 31, 2024
Equity [Abstract] |
STOCKHOLDERS' EQUITY | STOCKHOLDERS’ EQUITY Changes in the components of Stockholders’ equity were as follows for the periods indicated:
| Three months ended December 31
(Dollars in millions except per share data; shares in thousands) | Common stock |  | Additional paid-in capital |  | Retained earnings |  | Treasury stock |  | Accumulated other comprehensive net (loss) income |  | Noncontrolling interests |  | Total stockholders’ equity
Amount |  | Shares |  |  |  | Amount |  | Shares |  |  |
Balance as of September 30, 2023 | $ | 131 |  |  | 130,741 |  |  | $ | 1,246 |  |  | $ | 299 |  |  | $ | (1,219) |  |  | (6,740) |  |  | $ | (494) |  |  | $ | 168 |  |  | $ | 131 |
Net earnings | — |  |  | — |  |  | — |  |  | 93 |  |  | — |  |  | — |  |  | — |  |  | 3 |  |  | 96 |
Other comprehensive (loss) income | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 135 |  |  | — |  |  | 135 |
Dividends to Clorox stockholders ($1.20 per share declared) | — |  |  | — |  |  | — |  |  | (150) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (150) |
Dividends to noncontrolling interests | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (6) |  |  | (6) |
Stock-based compensation | — |  |  | — |  |  | 16 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 16 |
Other employee stock plan activities | — |  |  | — |  |  | (17) |  |  | (1) |  |  | 14 |  |  | 79 |  |  | — |  |  | — |  |  | (4) |
Balance as of December 31, 2023 | $ | 131 |  |  | 130,741 |  |  | $ | 1,245 |  |  | $ | 241 |  |  | $ | (1,205) |  |  | (6,661) |  |  | $ | (359) |  |  | $ | 165 |  |  | $ | 218 |
Balance as of September 30, 2024 | $ | 131 |  |  | 130,741 |  |  | $ | 1,297 |  |  | $ | 31 |  |  | $ | (1,252) |  |  | (7,068) |  |  | $ | (147) |  |  | $ | 164 |  |  | $ | 224 |
Net earnings | — |  |  | — |  |  | — |  |  | 193 |  |  | — |  |  | — |  |  | — |  |  | 1 |  |  | 194 |
Other comprehensive (loss) income | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (34) |  |  | — |  |  | (34) |
Dividends to Clorox stockholders ($1.22 per share declared) | — |  |  | — |  |  | — |  |  | (152) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (152) |
Dividends to noncontrolling interests | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (3) |  |  | (3) |
Stock-based compensation | — |  |  | — |  |  | 27 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 27 |
Other employee stock plan activities | — |  |  | — |  |  | (37) |  |  | (4) |  |  | 56 |  |  | 383 |  |  | — |  |  | — |  |  | 15 |
Treasury stock purchased | — |  |  | — |  |  | — |  |  | — |  |  | (150) |  |  | (906) |  |  | — |  |  | — |  |  | (150) |
Balance as of December 31, 2024 | $ | 131 |  |  | 130,741 |  |  | $ | 1,287 |  |  | $ | 68 |  |  | $ | (1,346) |  |  | (7,591) |  |  | $ | (181) |  |  | $ | 162 |  |  | $ | 121 |
| Six months ended December 31
(Dollars in millions except per share data; shares in thousands) | Common stock |  | Additional paid-in capital |  | Retained earnings |  | Treasury stock |  | Accumulated other comprehensive net (loss) income |  | Noncontrolling interests |  | Total stockholders’ equity
Amount |  | Shares |  |  |  | Amount |  | Shares |  |  |
Balance as of June 30, 2023 | $ | 131 |  |  | 130,741 |  |  | $ | 1,245 |  |  | $ | 583 |  |  | $ | (1,246) |  |  | (6,921) |  |  | $ | (493) |  |  | $ | 168 |  |  | $ | 388 |
Net earnings | — |  |  | — |  |  | — |  |  | 115 |  |  | — |  |  | — |  |  | — |  |  | 6 |  |  | 121 |
Other comprehensive (loss) income | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 134 |  |  | — |  |  | 134 |
Dividends to Clorox stockholders ($3.60 per share declared) | — |  |  | — |  |  | — |  |  | (450) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (450) |
Dividends to noncontrolling interests | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (9) |  |  | (9) |
Stock-based compensation | — |  |  | — |  |  | 29 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 29 |
Other employee stock plan activities | — |  |  | — |  |  | (29) |  |  | (7) |  |  | 41 |  |  | 260 |  |  | — |  |  | — |  |  | 5 |
Balance as of December 31, 2023 | $ | 131 |  |  | 130,741 |  |  | $ | 1,245 |  |  | $ | 241 |  |  | $ | (1,205) |  |  | (6,661) |  |  | $ | (359) |  |  | $ | 165 |  |  | $ | 218 |
Balance as of June 30, 2024 | $ | 131 |  |  | 130,741 |  |  | $ | 1,288 |  |  | $ | 250 |  |  | $ | (1,186) |  |  | (6,540) |  |  | $ | (155) |  |  | $ | 164 |  |  | $ | 492 |
Net earnings | — |  |  | — |  |  | — |  |  | 292 |  |  | — |  |  | — |  |  | — |  |  | 5 |  |  | 297 |
Other comprehensive (loss) income | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (26) |  |  | — |  |  | (26) |
Dividends to Clorox stockholders ($3.66 per share declared) | — |  |  | — |  |  | — |  |  | (457) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (457) |
Dividends to noncontrolling interests | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (7) |  |  | (7) |
Stock-based compensation | — |  |  | — |  |  | 40 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 40 |
Other employee stock plan activities | — |  |  | — |  |  | (41) |  |  | (17) |  |  | 97 |  |  | 644 |  |  | — |  |  | — |  |  | 39 |
Treasury stock purchased | — |  |  | — |  |  | — |  |  | — |  |  | (257) |  |  | (1,695) |  |  | — |  |  | — |  |  | (257) |
Balance as of December 31, 2024 | $ | 131 |  |  | 130,741 |  |  | $ | 1,287 |  |  | $ | 68 |  |  | $ | (1,346) |  |  | (7,591) |  |  | $ | (181) |  |  | $ | 162 |  |  | $ | 121 |
Changes in Accumulated other comprehensive net (loss) income attributable to Clorox by component were as follows for the periods indicated:
| Three months ended December 31
| Foreign currency translation adjustments |  | Net unrealized gains (losses) on derivatives |  | Pension and postretirement benefit adjustments |  | Accumulated other comprehensive net (loss) income
Balance as of September 30, 2023 | $ | (456) |  |  | $ | 98 |  |  | $ | (136) |  |  | $ | (494) |
Other comprehensive (loss) income before reclassifications | 17 |  |  | (6) |  |  | (7) |  |  | 4 |
Amounts reclassified from Accumulated other comprehensive net (loss) income (1) | — |  |  | (3) |  |  | 172 |  |  | 169 |
Income tax benefit (expense) | — |  |  | 1 |  |  | (39) |  |  | (38) |
Net current period other comprehensive (loss) income | 17 |  |  | (8) |  |  | 126 |  |  | 135 |
Balance as of December 31, 2023 | $ | (439) |  |  | $ | 90 |  |  | $ | (10) |  |  | $ | (359) |
Balance as of September 30, 2024 | $ | (225) |  |  | $ | 79 |  |  | $ | (1) |  |  | $ | (147) |
Other comprehensive (loss) income before reclassifications | (34) |  |  | 3 |  |  | — |  |  | (31) |
Amounts reclassified from Accumulated other comprehensive net (loss) income | — |  |  | (1) |  |  | (1) |  |  | (2) |
Income tax benefit (expense) | — |  |  | (1) |  |  | — |  |  | (1) |
Net current period other comprehensive (loss) income | (34) |  |  | 1 |  |  | (1) |  |  | (34) |
Balance as of December 31, 2024 | $ | (259) |  |  | $ | 80 |  |  | $ | (2) |  |  | $ | (181) |
| Six months ended December 31
| Foreign currency translation adjustments |  | Net unrealized gains (losses) on derivatives |  | Pension and postretirement benefit adjustments |  | Accumulated other comprehensive net (loss) income
Balance as of June 30, 2023 | $ | (445) |  |  | $ | 99 |  |  | $ | (147) |  |  | $ | (493) |
Other comprehensive (loss) income before reclassifications | 6 |  |  | (6) |  |  | 4 |  |  | 4 |
Amounts reclassified from Accumulated other comprehensive net (loss) income (1) | — |  |  | (4) |  |  | 175 |  |  | 171 |
Income tax benefit (expense) | — |  |  | 1 |  |  | (42) |  |  | (41) |
Net current period other comprehensive (loss) income | 6 |  |  | (9) |  |  | 137 |  |  | 134 |
Balance as of December 31, 2023 | $ | (439) |  |  | $ | 90 |  |  | $ | (10) |  |  | $ | (359) |
Balance as of June 30, 2024 | $ | (239) |  |  | $ | 85 |  |  | $ | (1) |  |  | $ | (155) |
Other comprehensive (loss) income before reclassifications | (20) |  |  | (1) |  |  | — |  |  | (21) |
Amounts reclassified from Accumulated other comprehensive net (loss) income | — |  |  | (3) |  |  | (1) |  |  | (4) |
Income tax benefit (expense) | — |  |  | (1) |  |  | — |  |  | (1) |
Net current period other comprehensive (loss) income | (20) |  |  | (5) |  |  | (1) |  |  | (26) |
Balance as of December 31, 2024 | $ | (259) |  |  | $ | 80 |  |  | $ | (2) |  |  | $ | (181) |
(1)Includes recognition of pension settlement charge reclassified into Net earnings. See Note 13 for additional details.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for equity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 16 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration